Home > Resources > Company Profiles > StemCells, Incorporated > News

StemCells, Incorporated (STEM)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Martin M. McGlynn , CEO/President/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Martin M. McGlynn, CEO/President/Director

3155 Porter Drive

Palo Alto, CA 94304

US Map it

Phone: (650) 475-3100

Fax: (650) 475-3101

www.stemcellsinc.com

Latest news from Portfolio


Overview

A biopharmaceutical company, which is engaged in the discovery and development of cell-based therapeutics to treat damage to,or degeneration of major organ systems.

Portfolio Articles
  • The Ultimare Cure
    The neurotech industry is engaged in a $2 trillion race to fix your brain. Many players will fail, but the payoff will be huge for those who succeed.
    May 12 2008

See more news on this company

Employees

Number of Employees: 63
Revenue per Employee: $856

Top Executives

George Koshy, Chief Accounting Officer
Rodney K.B. Young, CFO/Vice President, Divisional
Dr. Ann Tsukamoto, Ph.D., COO

Board of Directors

Financials

Quarterly
Annual

Income Statement 05/2008 03/2008 11/2007 07/2007
Sales -302.65 K. -305.08 K. -300.9 K. -302.05 K.
Gross Operating Profit 320 K. 334.85 K. 314.06 K. 309.89 K.
Operating Income before D & A (EBITDA) -6.43 Mil. -7.23 Mil. -7.43 Mil. -5.6 Mil.
Total Income Before Interest Expenses (EBIT) -6.52 Mil. -7.8 Mil. -7.12 Mil. -5.39 Mil.
Total Net Income -6.54 Mil. -7.83 Mil. -7.15 Mil. -5.42 Mil.
Basic EPS, Total -0.08 -0.09 -0.09 -0.07
Diluted EPS, Total -0.08 -0.09 -0.09 -0.07

BALANCE STATEMENT 05/2008 03/2008 11/2007 07/2007
Cash and Equivalents 12.61 Mil. 9.76 Mil. 17.53 Mil. 49.18 Mil.
Total Assets 31.41 Mil. 38.75 Mil. 44.68 Mil. 50.75 Mil.
Total Liabilities 4.22 Mil. 5.85 Mil. 5.1 Mil. 3.64 Mil.
Total Capitalization 29.76 Mil. 36.22 Mil. 41.74 Mil. 48.51 Mil.

Cash Flow 05/2008 03/2008 11/2007 07/2007
Net Cash From Continuing Operations -7.29 Mil. -20.86 Mil. -15.01 Mil. -10.11 Mil.
Net Cash From Investing Activities 10.18 Mil. -27.16 Mil. -23.98 Mil. 2.72 Mil.
Net Cash From Financing Activities -36.77 K. 5.98 Mil. 4.72 Mil. 4.77 Mil.
Net Change in Cash & Cash Equivalents 2.85 Mil. -42.04 Mil. -34.27 Mil. -2.61 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales -1.17 Mil. -1.04 Mil. -1.44 Mil. -1.87 Mil.
Gross Operating Profit 1.23 Mil. 1.14 Mil. 1.64 Mil. 2.01 Mil.
Operating Income before D & A (EBITDA) -26.63 Mil. -19.62 Mil. -14.95 Mil. -13.53 Mil.
Total Income Before Interest Expenses (EBIT) -24.9 Mil. -18.81 Mil. -11.57 Mil. -15.14 Mil.
Total Net Income -25.02 Mil. -18.95 Mil. -11.74 Mil. -15.33 Mil.
Basic EPS, Total -0.31 -0.25 -0.18 -0.31
Diluted EPS, Total -0.31 -0.25 -0.18 -0.31

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 9.76 Mil. 51.8 Mil. 34.54 Mil. 41.06 Mil.
Total Assets 38.75 Mil. 57.53 Mil. 35.13 Mil. 41.45 Mil.
Total Liabilities 5.85 Mil. 4.15 Mil. 3.55 Mil. 3.38 Mil.
Total Capitalization 36.22 Mil. 55.52 Mil. 32.38 Mil. 38.55 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations -20.86 Mil. -16.1 Mil. -11.87 Mil. -11.27 Mil.
Net Cash From Investing Activities -27.16 Mil. -1.3 Mil. -847.5 K. -748.3 K.
Net Cash From Financing Activities 5.98 Mil. 34.66 Mil. 6.2 Mil. 40 Mil.
Net Change in Cash & Cash Equivalents -42.04 Mil. 17.25 Mil. -6.52 Mil. 27.98 Mil.

powered by Interactive Data







News Volume

31 days volume

100%
80%
60%
40%
20%
0
August
September

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented